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Abstract 
Background: Attention is currently being drawn to child psychiatric care, most especially in the developed countries. 
This type of care is still rudimentary in the developing countries. Botswana is one of the African countries with good 
health care services but mental illness is given the low priority. Child and adolescent mental health care (CAMHC) is 
almost non‑existent likely due to the dearth of research which would drive a policy change in this direction. Hence 
the need for this research as a step towards establishing a well‑structured CAMHC.
Objectives: To determine the pattern of presentation of child psychiatric disorders and the predictors of poor treat‑
ment outcome in the national psychiatric hospital in Botswana.
Methods: This is a retrospective investigation comprising patients aged ≤17 years, consulting Sbrana Psychiatric 
Hospital over a 5‑year period. It involves extraction of information from 238 patients’ records on socio‑demographic 
characteristics, diagnosis and management.
Results: The most common diagnosis was Attention deficit hyperactivity disorder (ADHD) with a prevalence of 
25.2%. ADHD (60%) and Autism (58.3%) were more diagnosed in 5–9 years, whilst psychosis (80%) and depression 
(88.9%) amongst 14–17 years. Perinatal complication (OR 7.326, 95% CI: 1.312–40.899) and polypharmacy (OR 4.188, 
95% CI: 1.174–14.939) independently predicted poor treatment outcome, after logistic regression.
Conclusions: This study provided baseline information regarding children mental health in Botswana. It highlights 
the need for further research and to develop more specialized mental health care services for improved outcomes in 
children with mental health disorders.
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Background
In traditional African culture, it was previously assumed 
that mental illness “is unheard of” among children, (i.e., 
was inconceivable) [1], but recent epidemiological studies 
have revealed that psychiatric disorders are not only com-
mon but persistent, constituting about 30% of the global 
burden of illness in this age group [2–4]. Approximately, 
one in every five children and adolescents have a recog-
nizable & treatable mental disorder and more than half 
of adult psychiatric disorders begin before age 15 [5–7]. 
Disorders most commonly encountered in both com-
munity and hospitals include epilepsy, conduct disorder 
(CD), anxiety/emotional disorders, mixed disorders of 
conduct and emotions, attention deficit hyperactivity 
disorders (ADHD), major affective disorders, pervasive 
developmental disorders, specific developmental disor-
ders, psychoses, enuresis and mental retardation [8–10].
Pattern of presentation of child psychiatric disorders 
vary across different regions [8, 9]. In a study conducted 
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in America, the most common diagnosis made was 
ADHD (43%), followed by CD (30%), while depressive 
disorders and Schizophrenia were 27 and 5% respectively 
[10]. Another study from Saudi Arabia revealed mental 
retardation with a prevalence (30.2%) and anxiety dis-
orders (16%) as the most commonly encountered disor-
ders [11], while Schizophrenia 50% and delirium (15%) 
were the most diagnosed in a Nigerian study [12]. Rea-
sons for variation in presentation at different locations 
include age at presentation, delay in seeking help due to 
lack of awareness, poor socioeconomic status, waiting for 
more severe symptoms to appear, birth order and limited 
insurance coverage among others [8–12].
Pattern of presentation also varies according to age and 
gender, with diagnosis changing in individual patients 
with increasing age and frequently higher proportion of 
males than females [8–12]. Enuresis, feeding problems 
and developmental disorders are frequently seen in early 
childhood while Psychotic disorders such as schizo-
phrenia rarely occur before age 14, but show a marked 
increase in prevalence after 15  years. Depression and 
drug abuse frequently start and are common in adoles-
cence [5, 8–10, 13].
The effect of child disorders without early and ade-
quate intervention are quite enormous and have serious 
consequences in their lives, the family and the society 
at large [9]. They commonly lead to underachievement, 
dependence or even delinquency depending on the type 
of disorder [8, 9]. Early recognition and prompt inter-
vention have been shown to reduce mental health dis-
ease burden and improve quality of life in children and 
adolescents [14]. Nevertheless, studies from Europe and 
America have suggested some factors which to a large 
extent influence disease course and treatment outcome 
[15–17]. These include treatment adherence, family sta-
bility, polypharmacy, perinatal complication, nature of 
illness (externalizing versus internalizing) presence of 
co-morbid psychological/medical disorders; stressful life 
events, lack of specialized care and so on. These factors 
either influence treatment outcome directly or indirectly 
by influencing treatment adherence [11, 15–17].
Many of these factors are increasingly being addressed 
with the advent of specialized child and adolescent care, 
an improvement on the period when children with psy-
chiatric disorders were being cared for by general adult 
psychiatrists [8, 9, 12]. Specialized child and adolescent 
care involves the use of a multidisciplinary care team 
which include child psychiatrists, child psychologists, 
speech therapists, social workers, neuropsychiatrists, 
educational occupational therapists among others and 
has greatly improved quality of care and reduced disease 
burden as well as treatment outcome [8, 9]. This type of 
care is still very rudimentary in the developing countries 
and the reasons for this are diverse [18]. Factors rang-
ing from low socio-economic status, illiteracy and poor 
infrastructure are partly responsible [12, 19]. The impact 
of the perception in many African countries that child-
hood mental disorders are not medical conditions can-
not be overemphasized [12]. Whilst some externalizing 
childhood mental disorders such as ADHD and CD are 
seen as “stubbornness,” with parents encouraged to resort 
to punitive corrective measures, Internalizing disorders 
such as autism and depression are linked to witchcraft 
with traditional or spiritual help being often sought. Bot-
swana is not excluded from the usual African perception 
and practice of exhausting the traditional method of care 
before consulting the orthodox care, resulting in delayed 
presentation or presentation at the very severe state [20]. 
Of note is the “defective” family system which is charac-
terized by non-marital childbearing, increasing number 
of female-headed households and the resultant poor fam-
ily support. This has been shown to have negative effect 
on child health and plays a vital role in causing delay in 
help seeking [21].
Low priority for mental health care is another major 
factor which is not unconnected to the dearth of research 
to drive policies in favor of this field of medicine [22]. 
Botswana is among the middle income countries in 
Africa. It is rated 15th by the World Bank in terms of 
Gross National Income per capita (GNI). Its percent-
age of GDP on health care expenditure in 2013 was 5.4% 
which is lower than that of its neighbour South Africa, 
another middle income country with GNI rating of 12th 
and 8.8% total expenditure on health as percentage of 
GDP [23]. Services are available free for citizens at all lev-
els of health care with 60.01% of funding for healthcare 
in Botswana being provided for by the government com-
pared to the average for the African region of 48.5 [24]. 
In many other countries in Africa such as Nigeria, health 
care financing is mostly out of pocket [20, 24, 25]. How-
ever, mental illness is given the low priority in Botswana, 
with only 1% of the total health budget spent on mental 
health, compared to South Africa with up to 8% in some 
districts [23, 26]. This is further buttressed by World 
Health Organization report in 2011, which indicated that 
there were 0.25 general adult psychiatrists, 0.51 non-psy-
chiatrists, 0.35 social workers and 1.52 psychologists per 
100,000 population in Botswana [27].
Moreover, there is currently no child psychiatrist in 
Botswana, hence, quality mental health care for this 
group of individuals is almost non-existent. For the 
past five years, the only psychiatric facility in Botswana 
has been attending to the needs of children with men-
tal disorders without any specialized care unit. This 
invariably implies that they are being seen together with 
adults; a type of care that is often associated with stigma, 
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inadequate attention to health needs, and consequent 
poor treatment outcome [12]. Lack of data to prove the 
existence of child psychiatric disorders is largely respon-
sible for this low priority given to child mental health 
and its attendant poor treatment outcome in the devel-
oping countries [18, 22]. We thus believe that, assess-
ing the diagnostic profiles as well as factors influencing 
treatment outcome in the only mental health facility can 
not only inform a policy change in favor of CAMHC in 
Botswana, but also lay a foundation for a well-structured 
health care services for this group of people.
Methods
Study design and population
The study is a retrospective investigation, which involved 
extraction of information from the records of the patients 
(17  years and below) who attended Sbrana Psychiatric 
Hospital (SPH) between 1 January 2012 and 31 July 2016.
Study location
SPH, Lobatse, is the only mental health referral hospital 
in Botswana and is government owned, which informed 
its use for thus study. It is a 300-bed facility located in the 
southern-eastern part of Botswana. The hospital offers 
both Out-patient and In-patient as well as day hospital 
care service. The hospital accepts all types of mental dis-
orders, ranging from minor to the severe ones and serves 
as the only mental health referral facility for all the health 
institutions (private, public and all levels of health cares) 
in the country. The hospital provides for the psychiatric 
treatment of both adult and child mental and behavioral 
disorders. Other facilities available are psychology, soci-
ology, occupational therapy, pharmacy, laboratory and 
community services.
Sampling and data collection procedure
The hospital numbers of all the children and adolescents 
below 18  years were retrieved from the hospital com-
puterized record system and used to retrieve patients’ 
files from the medical record library. A semi structured 
instrument was designed to assist in extraction of infor-
mation from the case notes. These include information 
on the patient socio-demographic profile (age, gender, 
parents’ profiles, educational history and family history), 
clinical and management characteristics of the patients, 
such as, presenting symptoms, diagnostic classification 
patients’ management, and information on follow-up 
visits. SPH prides itself on proper documentation and a 
very good (computerized) record keeping which makes 
data extraction for research purposes easy. Moreover, 
clinical audits are conducted from time to time to ensure 
strict adherence to proper documentation. As a rule, all 
patients’ case files in SPH contain notes/input from every 
member of multidisciplinary team involved in patients’ 
care. These include, Birth records, reviews (psychiatric 
and medical), investigations, diagnoses, management and 
follow-up notes. Also included in all the files are case/
discharge summaries with ICD-10 diagnoses.
All the researchers agreed on the designed pro-forma 
and all the information to be extracted from patients’ 
files, but only two of the researchers who are hospi-
tal specialists extracted the information. Every issue 
that needed clarification was discussed frequently and 
resolved. The two researchers who extracted the infor-
mation worked together and agreed on the diagnosis, 
treatment outcome and any other sensitive information 
before they are finally entered into the instruments. 
Those records on which agreement could not be reached 
were excluded. This was done for all the records reviewed 
to avoid double coding.
The final and the major diagnoses were recorded. How-
ever, in those with co-occurring psychiatric disorders, the 
second and third diagnosis were recorded as multiple diag-
noses. Treatment outcome was based on the agreement 
of the subjective remarks of the managing team which 
include the attending consultant psychiatrists, the psychol-
ogists, social workers, occupational therapists, psychiatric 
nurses and the relatives. These reports were majorly based 
on alleviation of symptoms and restoration of functions, 
as documented in the patients’ files. Outcome was one of 
these three possible options: Good (Improved) treatment 
outcome was used when most or all of the symptoms have 
subsided and patients’ functioning have either improved 
considerable or totally restored as assessed by the manag-
ing team. Poor treatment outcome was used when most of 
the symptoms were still present and the patient was unable 
to maintain adequate level of function particularly in the 
activities of daily living after at least 3 months of treatment. 
The third group comprise of those who either defaulted 
after the first visit or whose outcome could not be deter-
mined most especially due to poor documentation.
Ethical considerations
Ethical approval was obtained from the University of Bot-
swana ethical committee. Permission to access patients’ 
records was also sought from the ministry of health and 
the management of SPH.
Data analysis
Data analysis was done using the Statistical Package for 
Social Sciences (SPSS for windows 16.0, SPSS Inc., Chicago, 
IL, USA). Frequency tables were employed for descriptive 
statistics such as socio-demographics, diagnosis and other 
clinical variables. Cross-tabulations were done to show the 
relationships between identified risk factors (socio-demo-
graphics and clinical variables) and treatment outcomes 
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using Chi square test. The variables that were significantly 
associated with outcome were further entered into stepwise 
multiple regression analysis with backward elimination with 
poor treatment outcome as the dependent variable. The level 
of statistical significance was set at p < 0.05.
Results
Socio‑demographics
The records of 238 of 251 patients aged 17  years and 
below, seen between 1 January 2012 and 31 July 2016 were 
extracted and analyzed. Thirteen case notes were totally 
left out due poor documentation. The mean age of the 
patients was 12.41(SD 4.1). Members of the male gender 
(60.5%) outnumbered that of their female (39.5%) coun-
terparts. Majority (60.9%) of the patients came from the 
South and South-east district. Many of these children and 
adolescents came from families with 4 or less number of 
siblings (77.5%) and only 90 (39.6%) were the first-born. 
Of the 238 records extracted, only 200 had full documen-
tation on parents’ marital status and these revealed that 
only 26 (13%) parents were married. In addition, only in 39 
(17.6%) cases were both parents part of the patients’ care. 
The most common source of referral was from the parents/
relatives accounting for 37.6%. Twenty-three (10.4%) were 
referred from the social welfare and the police while only 
sixteen (7.2%) were referred from the tertiary hospitals.
Diagnosis
Using ICD-10 diagnostic criteria, the final diagnosis of 
each patient was extracted from the hospital records. The 
most common overall diagnosis (including single and 
multiple) was ADHD 60 (25.2%) followed by disruptive 
behavior disorder (DBD) 44 (18.5%) (Fig.  1). One hun-
dred and twenty-nine (54.2%) had single diagnosis, while 
the remaining had more than one diagnosis. ADHD was 
the commonest single diagnosis, accounting for 22.5% of 
the 129 with single diagnosis followed by adjustment dis-
order (14%), psychosis, including schizophrenia (11.6%) 
and DBD (8.5%). The three most commonly occurring 
pairs of diagnoses were ADHD and DBD (12%), sub-
stance related disorders and psychosis (9.2%) and ADHD 
and mental retardation (7.3%).
ADHD and Autism were significantly most frequently 
diagnosed in 5–9  years, whilst adjustment disorder, 
substance related disorders, psychosis, which includes 
schizophrenia and depression occurred most commonly 
amongst patients aged 14–17 years (Table 1). In the same 
vein, ADHD, autism and schizophrenia were commoner 
among males with depression and adjustment disorder 
common among females (Table  2). Only 18 (7.6%) had 
physical/medical co-morbidity of which the most com-
mon was speech and hearing impairment (33.3%), fol-
lowed by congenital abnormality and physical deformity 
which were both 11.2%.
Identified risk factors and treatment outcome
Of the 238 patients, 109 (45.8%) had improved as at the last 
time they were reviewed, 78 (32.8%) had poor treatment 
outcome, while the remaining 51 (21.4) were excluded 







Fig. 1 DBD disruptive behaviour disorder, MR mental retardation, ADHD attention deficit hyperactivity disorder, DO disorder, Others tic disorder, 
obsessive compulsive disorder, other stress related disorder such as acute stress reaction, posttraumatic stress disorders, organic disorders
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or default after first visit. Seventy-seven (70.6%) of those 
who had good treatment outcome were 11 years and above 
(χ2 = 6.382, p = 0.012). Male patients were more likely to 
have poor treatment outcome compared to their female 
counterparts (χ2 = 4.343, p = 0.037). Those who had peri-
natal complications or early childhood illness were more 
likely to have poor outcome than those with uneventful 
perinatal history (χ2 = 4.937, p = 0.026) or without early 
childhood illness (χ2  =  4.218, p  =  0.040). Other factors 
that were associated with poor treatment outcome include 
out-patient mode of care (χ2 = 31.072, p < 0.01) and poly-
therapy (χ2  =  7.197, p  =  0.007). Specialist (general psy-
chiatrist) care on the other hand was associated with good 
treatment outcome (χ2 = 7.238, p = 0.007) (Table 3).
Multiple regression analysis of the risk factors for poor 
treatment outcomes
The identified risk factors that were significant on bivari-
ate analysis were entered into a multiple regression 
model with backward elimination which involved 4 steps. 
Early childhood illness and gender were the first variables 
to exit the model at step 2 and 3 respectively. Age group, 
place of management and specialist were also eliminated 
from step 4 of the regression model. The remaining two 
independent variables: namely perinatal complication 
(OR 7.326, p  =  0.023, 95% CI: 1.312–40.899) and pre-
scribing pattern (OR 4.188, p  =  0.027, 95% CI: 1.174–
14.939) were produced by the model (Table 4). The model 
summary revealed a Nagelkerke R2 of 0.519 and thus 
implies that these two variables explains 51.9% of the var-
iance in predicting poor treatment outcome.
Table 1 Frequency of the overall diagnosis by age
do disorder, DBD disruptive behavior disorders include conduct disorder and oppositional defiant disorder, ADHD attention deficit hyperactivity, psychosis 
schizophrenia and other psychotic do, Others Tic do, obsessive compulsive do, stress related do, organic do
* Fisher’s exact test
N* = 238. Significant relationships in italics
Frequency of diagnosis Age, N* (%) Chi square p value
1–4 5–9 10–13 14–17
N = 10 N = 57 N = 50 N = 121
ADHD 8 (13.3) 36 (60.0) 11 (18.3) 5 (8.3) 88.241 <0.01
DBD 3 (6.8) 15 (34.1) 11 (25.0) 15 (34.1) 7.041 0.061*
Epilepsy 1 (3.6) 4 (14.3) 4 (14.3) 19 (67.9) 3.412 0.312*
Substance related do 0 (0) 0 (0) 1 (2.9) 33 (97.1) 36.603 <0.01*
Autism 1 (8.3) 7 (58.3) 2 (16.7) 2 (16.7) 9.426 0.014*
Mental retardation 1 (3.4) 10 (34.5) 9 (31.0) 9 (31.0) 5.954 0.096*
Bipolar mood do 0 (0) 0 (0) 2 (33.3) 4 (66.7) 2.274 0.506*
Depressive do 0 (0) 1 (5.6) 1 (5.6) 16 (88.9) 9.822 0.015*
Psychosis 0 (0) 1 (2.9) 6 (17.1) 28 (80.0) 17.409 0.001*
Anxiety disorder 0 (0) 3 (18.8) 6 (37.5) 7 (43.8) 2.483 0.447*
Adjustment do 0 (0) 2 (6.9) 5 (17.2) 22 (75.9) 9.042 0.023*
Enuresis 0 (0) 4 (40.0) 4 (40.0) 2 (20.0) 5.148 0.135*
Somatoform do 0 (0) 0 (0) 4 (66.7) 2 (33.3) 5.930 0.066*
Others 1 (8.3) 5 (41.7) 2 (16.7) 4 (33.3) 3.587 0.279*
Table 2 Frequency of the overall diagnosis by gender
do disorder, DBD disruptive behavior disorders include conduct disorder and 
oppositional defiant disorder, ADHD attention deficit hyperactivity, psychosis 
schizophrenia and other psychotic do, Others Tic do, obsessive compulsive do, 
stress related do, organic do
* Fisher’s exact test




Gender Chi square p value
Male N (%) Female N (%)
ADHD 47 (78.3) 13 (21.7) 10.672 0.01
DBD 31 (70.5) 13 (29.5) 2.236 0.135
Epilepsy 15 (53.6) 13 (46.4) 0.638 0.424
Substance related 
do
28 (82.4) 6 (17.6) 7.924 0.005
Autism 11 (91.7) 1 (8.3) 5.135 0.031*
Mental retardation 24 (82.8) 5 (17.2) 6.844 0.009
Bipolar mood do 3 (50.0) 3 (50.0) 0.284 0.683*
Depressive do 3 (16.7) 15 (83.3) 15.660 <0.01*
Psychosis 27 (77.1) 8 (22.9) 4.754 0.029
Anxiety disorder 5 (31.2) 11 (68.8) 6.143 0.013
Adjustment do 9 (31.0) 20 (69.0) 12.002 0.001
Enuresis 7 (70.0) 2 (30.0) 0.408 0.744*
Somatoform do 2 (33.3) 4 (66.7) 1.902 0.174*
Others 7 (58.3) 5 (41.7) 0.25 0.875
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Discussion
The results of the study demonstrated that childhood 
psychiatric disorders are clearly present in Botswana as 
in the rest of Africa [12, 18, 29] and they are being rec-
ognized and referred for psychiatric care. It is note-
worthy that between January 2012 and July 2016, only 
251 patients in the child and adolescent age range were 
recorded. This implies that the belief that childhood psy-
chiatric disorder “is unheard of” still exists in Botswana. 
Although there is no published data to substantiate the 
possibility of underutilization of child psychiatric ser-
vices when compared to the general adult service in the 
same facility, the hospital records revealed that an aver-
age of 100 new adult cases presented in a year. Moreo-
ver, in a population of over 2million with approximately 
43% below the age of 19  years [28], this figure demon-
strates the probability of significant unmet need of child 
and adolescent mental health. Nonetheless, a community 
study would be required to establish the level of aware-
ness and service utilization.
The mean age of 12.41  years is consistent with those 
of the American study and a study from West Africa [10, 
29]. The age range was 2–17 years and the upper limit of 
17 year is in agreement with a West African study, where 
patient who are already 18  years are being treated as 
adult [29]. Male preponderance was noted in this group, 
as in many other studies in children, including the com-
munity based ones [2, 3, 8, 9]. The overrepresentation 
(60.9%) of those from the South-west and Southern part 
of Botswana may simply be a reflection of the location of 
the facility and thus suggests a skewness in the coverage 
of the facility and its community outreach programs.
It is not surprising that most of the informants/caregiv-
ers were mother comprising of 57.1% of the 182 single 
parent or others, because of the increasing emergence of 
non-marital child bearing and female headship in Bot-
swana [21]. In the same vein, a large proportion (37.6%) 
of patients presented without any formal referral, a prob-
able effect of the community mental health outreach of 
the hospital. Despite its drawbacks which is majorly due 
to shortage of personnel and the fact that it was mostly 
Table 3 The relationship between  identified risk factors 
and treatment outcome
Risk factors Outcome N* (%) df χ2 p
Good Poor
Age group
 ≤10 32 (46.4) 37 (53.6) 1 6.382 0.012
 ≥11 77 (65.3) 41 (34.7)
Gender
 Female 47 (68.1) 22 (31.9) 1 4.343 0.037
 Male 62 (52.5) 56 (47.5)
No of sibling
 4 or less 86 (59.3) 59 (40.7) 1 0.133 0.715
 5 or more 19 (55.9) 15 (44.1)
Order of birth
 First born 37 (50.7) 36 (49.3) 1 3.233 0.072
 Others 68 (64.2) 38 (35.2)
Family type
 Same parents 38 (63.3) 22 (36.7) 1 1.371 0.242
 Different parents 60 (54.1) 51 (45.9)
Care giver
 Both parents 18 (51.4) 17 (48.6) 1 0.622 0.430
 Single parent and others 80 (58.8) 56 (41.2)
Past psychiatric history
 Absent 23 (71.9) 9 (28.1) 1 2.931 0.087
 Present 86 (55.5) 69 (44.5)
Medical history
 Absent 102 (58.4) 73 (41.7) 1 0.000 0.997
 Present 7 (58.3) 5 (41.7)
Family history
 Absent 67 (58.8) 47 (41.2) 1 0.016 0.901
 Present 37 (57.8) 27 (42.2)
Perinatal complication
 Absent 87 (61.7) 54 (38.3) 1 4.937 0.026
 Present 9 (37.5) 15 (62.5)
Early childhood illness
 Absence 71 (64.0) 40 (36.0) 1 4.218 0.040
 Presence 26 (47.3) 29 (52.7)
Psychiatric co‑morbidity
 Absent 60 (61.9) 37 (38.1) 1 1.055 0.304
 Present 49 (54.4) 41 (45.6)
Physical co‑morbidity
 Absent 99 (57.2) 74 (42.8) 1 1.075 0.300
 Present 10 (71.4) 4 (28.6)
Mode of care
 In‑patient 43 (93.5) 3 (6.3) 1 31.072 <0.01
 Out‑patient 66 (46.8) 75 (53.2)
Type of intervention
 Only Pharmacological 19 (51.4) 18 (48.6) 1 0.913 0.339
 Only Psychological or both 90 (60.0) 60 (40.0)
Specialist (General psychiatrist) care
 Given 90 (63.8) 51 (36.2) 1 7.238 0.007
Table 3 continued
Risk factors Outcome N* (%) df χ2 p
Good Poor
 Not given 19 (41.3) 27 (58.7)
Prescribing pattern
 Monotherapy 50 (71.4) 20 (28.6) 1 7.197 0.007
 Poly‑therapy 14 (43.8) 18 (56.2)
χ2  Chi square, df   degree of freedom, p  p value
N* = N not equal to 238 due to missing data; only those with good (improved) 
and Poor treatment outcome (187) were analysed, those who defaulted after the 
first visit (51) were excluded from analysis. Significant p value in italics
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targeted at the general adult mental health [20], it may 
have positively influenced the awareness of child mental 
health among parents and families who have benefited 
from the hospital services through snow-balling.
Externalizing disorders such as ADHD and DBD pre-
sented relatively more often, followed by Psychotic dis-
orders. While our study agrees to an extent with that of 
the American study where ADHD and DBD were pre-
dominant [10], it differs from a study in Nigeria whose 
commonly encountered disorder was schizophrenia [12]. 
This may be a result of the comprehensive free health 
program available for all citizens of Botswana as against 
out of pocket payment which predominates in Nigeria 
and many other African countries [25]. The absence of a 
financial barrier to seeking care may help presentation at 
the clinical setting to more closely mirror the prevalence 
in the community. In Botswana, over 60% of total health-
care funding is provided by the government with only 
about 5% funding being out of pocket payment as com-
pared to about 23% of government funding and almost 
73% out of pocket funding in Nigeria [23]. In addition, 
the mean age in the current study and the American 
were 12.41 and 11.9 respectively, unlike in the Nigerian 
study (16.38) where schizophrenia and other disorders 
more specific to the older age group are expected. The 
availability of a government funded free health pro-
gram removes a critical barrier to help seeking. This in 
turn enables parents to seek professional help for child-
hood behavioral disorders like ADHD and DBD, which 
might have otherwise been construed as “stubbornness”. 
Moreover, it is not unexpected that childhood disorders 
of externalizing type are by nature disruptive and easier 
to identify as problems. Nonetheless, it will be necessary 
to compare this result with a community based study in 
the same population to determine if our finding is a true 
reflection of the incidence or due to lack of identification 
of other disorders.
The age related frequency of diagnoses demonstrate 
that the presentation follows a similar pattern to the 
known age of onset of childhood psychiatric disorders 
[8–10] with ADHD presenting more commonly in age 
5–9  years (χ2  =  88.241; p  <  001), while other known 
disorders more commonly seen in adolescents as com-
pare to early childhood such as depressive disorders 
(FET  =  9.822; p  =  0.015), substance related disorders 
(FET =  36.603; p  <  0,01) and psychosis such as schizo-
phrenia (FET = 17.409; p = 0.001) presented more often 
within 14–17 years [8–10, 12]. A pattern of gender dis-
tribution similar to what has been documented was also 
seen, with ADHD, autism and schizophrenia being more 
often diagnosed among males, while depressive disorders 
and anxiety disorders were diagnosed more often among 
females [8–10, 22]. This pattern may indirectly indicate 
that the relative presentations mirror the pattern in the 
community. It is however impossible to come to this con-
clusion until a community study is done to compare the 
findings.
We found that those who were above 10  years were 
more likely to achieve a good treatment outcome compare 
to those who were 10 and below (χ2 = 6.382, p = 0.012). 
Possibly, the higher success rate achieved in the older age 
group may be due to the fact that the disorder most com-
monly presented at these age group were the same as those 
found in adults, for which the available specialist were spe-
cifically trained for, since they are all general adult psychia-
trist. In a similar manner, gender is seen to be significantly 
Table 4 Multiple regression analysis of  the risk factors 
for poor treatment outcomes
OR  odd ratio, CI  confidence interval








Risk factors P value OR 95% CI
Lower Upper
Step1
 Age groupa 0.349 1.830 0.516 6.490
 Genderb 0.353 1.888 0.493 7.223
 Perinatal complicationc 0.027 7.861 1.271 48.620
 Early childhood illnessd 0.759 0.815 0.221 3.013
 Place of managemente 0.998 2.854E9 0.000 –
 Specialist caref 0.147 3.679 0.633 21.385
 Prescribing patterng 0.016 5.235 1.361 20.140
Step 2
 Age group 0.294 1.925 0.566 6.552
 Gender 0.360 1.868 0.490 7.118
 Perinatal complication 0.028 7.428 1.246 44.278
 Place of management 0.998 2.772E9 0.000 –
 Specialist care 0.114 3.954 0.718 21.779
 Prescribing pattern 0.017 5.136 1.346 19.597
Step 3
 Age group 0.379 1.711 0.517 5.661
 Perinatal complication 0.019 8.335 1.414 49.144
 Place of management 0.998 3.525E9 0.000 –
 Specialist care 0.122 3.688 0.706 19.265
 Prescribing pattern 0.021 4.780 1.265 18.062
Step 4
 Specialist care 0.088 4.110 0.809 20.881
 Perinatal complication 0.023 7.326 1.312 40.899
 Prescribing pattern 0.027 4.188 1.174 14.939
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associated with the outcome, with female gender hav-
ing higher rates of good treatment outcome. This may be 
explained by the male preponderance of chronic childhood 
and adolescent behavioral disorders including ADHD 
(78.3%), Autism (91.7%), mental retardation (82.8%) and 
substance related disorders (82.4%) as compared with the 
female preponderance of emotional disorders such as anx-
iety disorders (68.8%) and adjustment disorders (69.0%). 
In addition males had a higher proportion of diagnosis of 
psychoses (77.1%). This distribution may simply be as a 
result of identification bias. It has previously been reported 
that the female gender present less disruptive symptoms 
than their male counterpart even within diagnostic cat-
egories [30]. It is noteworthy however that gender dispar-
ity in the presentation and diagnoses of mental disorders 
have been noted in adult populations [31–33]. Neverthe-
less, neither age nor gender significantly contributed to 
the prediction of poor treatment outcome after a multiple 
regression analysis as reported by a more recent study with 
similar design [11, 29].
One would expect a significant relationship between 
family characteristics such as family type, number of 
siblings, parent’s marital status, and poor treatment out-
come as documented in previous reports [8, 9, 34]. Simi-
lar to what was reported by Al-Habeeb et al., we did not 
observe any association between these variables, possibly 
because heath care provision in Botswana is free for all 
the citizens at all levels including tertiary level of care. 
This may have significantly reduced the burden of care on 
the family.
The mode of care, whether in-patient or out patient 
is largely dependent on the age, severity and the type of 
disorder [8]. The older patient with severe disorders such 
as schizophrenia and depression are more likely to be 
admitted while younger children with ADHD and autism 
were more likely to have out-patient mode of care [8, 9, 
12]. In the current study, 44 out of 46 who had inpatient 
care were above 10 years and thus fell into the category 
of those with disorder similar to the general adult psy-
chiatry which the hospital is adequately equipped for. 
This may partly explain the association observed between 
in-patient care and good outcome (χ2 = 31.07, p < 0.01) 
in this study. In addition, patient on admission can easily 
be monitored and may not be discharged until they have 
improved. Notwithstanding this association with bivari-
ate analysis, mode of care does not explain any variance 
in the regression model similar to the report of previous 
authors [8, 9, 11].
Studies have established an association between peri-
natal complication early childhood illnesses and various 
child and adolescent psychiatric disorders. Some of these 
complications cause permanent damage to the brain 
which may present with psychiatric disorders especially 
when they later encounter adverse psychosocial events 
[8, 9]. These complication at times may be very elusive 
or difficult to detect, thus making some psychiatric dis-
order very difficult to treat. It is therefore not astound-
ing that we found an association between perinatal 
complication and poor treatment outcome (χ2  =  4.937, 
p =  0.026) as in previous reports [8, 9, 11]. Those who 
reported perinatal complication were 7 times more likely 
to have a poor treatment outcome in this study (OR 
7.326, 95% CI: 1.312–40.899). This suggests the need for 
more specialized care which involves looking beyond 
psychiatric manifestation of possibly undetected organic 
damage. Even though one may not expect the same level 
of improvement as in those without brain damage, but a 
more specialized care would improve functioning as well 
as quality of life [8, 9].
Another variable that contributed significantly to the 
prediction of poor treatment outcome is the prescribing 
pattern. The current study revealed that, those that were 
treated with more than one medication at a time were 4 
more times likely to have a poor treatment outcome (OR 
4.188, 95% CI: 1.174–14.939). Psychiatric polypharmacy 
has been defined as the prescription of two or more psy-
chiatric medications concurrently to a patient [35, 36]. 
This has been described in the elderly [37] and in chil-
dren [38]. More than a quarter (31.4%) of the patient on 
pharmacotherapy in the current study are in this category 
and a significant number of them had a poor treatment 
outcome (χ2 = 7.197, p = 0.007). The reasons for polyp-
harmacy have been widely discussed [35, 36]. The prac-
tice could be that a therapist finds that the administration 
of a single medication was ineffective in treating psychi-
atric symptoms [35, 36]. It could be to treat side/adverse 
effects, co-morbid psychological or physical symp-
toms, and diagnostic dilemma, among others. Although 
one could not pin-point the reasons for polypharmacy 
amongst our sample, but the presence of co-morbid psy-
chological disorder (45%) which may be related to peri-
natal complication is suggestive.
Polypharmacy has been shown to be associated with 
poor treatment outcomes for the following reasons: 
increased vulnerability to adverse reactions, poor com-
pliance and drug interaction, induction of liver enzyme 
which may reduce bioavailability of the major drugs [39, 
40]. Clearly, there are some times when polypharmacy 
is necessary, particularly in the treatment of adverse/
side effect of the major medication and co-morbidity. 
Its negative effect on treatment outcome can be signifi-
cantly addressed through rational prescribing or using 
the concept of “personalized medicine” [35]. This further 
highlights the need for specialized child and adolescent 
mental health care in the country, where children will 
only be attended to by those who are specially trained to 
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identify their need and deliver a tailored mental health 
care to them.
Recommendations
Following the findings of this study, a specialized training 
is recommended for interested members of professional 
staff whose services will be dedicated only to children 
and adolescents’ mental health care and research. The 
current drive towards increasing awareness of men-
tal health disorders and treatment should be sustained 
and strengthened. Particular attention should be given 
to increasing the geographical spread of the awareness 
programs and increasing its focus on child and adoles-
cent mental health disorders. Adequate management of 
perinatal period is advocated as a preventive measure for 
mental disorders in children and adolescents.
Limitations and strengths
This study highlights the pattern of psychiatric disorder 
and the factors that influence the outcome of service 
delivery to the children and adolescent in the only psy-
chiatric referral hospital in Botswana. Thus the findings 
must be interpreted with caution, owing to the reliance 
on the hospital record and the reports of the managing 
team which could be subjective. The generalizability of 
the study to the general population is also limited being a 
hospital-based study. Nevertheless, consistent rules were 
used in the selection of the samples and this screened 
out incomplete records which were either controversial 
or not informative. All the authors communicated from 
time to time and agreed on these rules, but the extraction 
was done by two of the hospital consultants (psychiatric 
specialists) who were part of the study. In addition, only 
the results that were agreed upon by all the members of 
the managing team were used for the analysis.
Future research
Our study suggests a possibility of low psychiatric service 
utilization in Botswana, however, this is difficult to estab-
lish without a community study to compare with, thus 
indicating a need for community studies.
The Nagelkerke R2  =  0.519 indicates a moderately 
strong relationship between the predictors and the 
prediction. In other words, the two independent vari-
ables namely: perinatal complication and polypharmacy 
explain 51.9% of the variance in predicting a poor treat-
ment outcome. This perhaps suggests that other factors 
which comprise of the remaining 48.1% related to the 
poor treatment outcome are yet to be investigated. These 
factors may include type and nature of psychiatric disor-
ders, adherence, and other socio-cultural factors which 
may form the subject for further research. Other rele-
vant research questions may include the sustainability of 
treatment under the comprehensive free medical cover-
age and quality and types of medications being used.
Conclusions
This study has provided baseline information regarding 
child and adolescent mental health in Botswana. It pro-
vided a broad idea of the commonly encountered child 
psychiatric disorder by age and sex in the only mental 
referral hospital in Botswana.
Only two (perinatal complication and polypharmacy) 
of all the risk factors associated with poor treatment out-
come emerged as its independent predictors. Whilst the 
non-modifiable factor namely perinatal complication 
suggests the need to improve our antenatal care, polyp-
harmacy indicates the need for more specialized care for 
children with mental disorders.
Finally, our study highlights the need for further 
research in this psychiatric subspecialty for improved 
outcomes in children and adolescents with mental health 
disorders.
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